CAH vs. COR, MCK, ICLR, ZBH, ALGN, RMD, ARGX, BIIB, WST, and MOH
Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include Cencora (COR), McKesson (MCK), ICON Public (ICLR), Zimmer Biomet (ZBH), Align Technology (ALGN), ResMed (RMD), argenx (ARGX), Biogen (BIIB), West Pharmaceutical Services (WST), and Molina Healthcare (MOH). These companies are all part of the "medical" sector.
Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends, valuation and community ranking.
Cardinal Health pays an annual dividend of $2.00 per share and has a dividend yield of 1.9%. Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.8%. Cardinal Health pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora pays out 22.2% of its earnings in the form of a dividend.
Cencora has higher revenue and earnings than Cardinal Health. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.
Cardinal Health currently has a consensus price target of $103.07, indicating a potential downside of 0.12%. Cencora has a consensus price target of $218.22, indicating a potential downside of 9.41%. Given Cardinal Health's higher probable upside, analysts clearly believe Cardinal Health is more favorable than Cencora.
87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.2% of Cardinal Health shares are held by insiders. Comparatively, 15.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Cardinal Health has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.
Cardinal Health received 164 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 71.68% of users gave Cardinal Health an outperform vote while only 65.03% of users gave Cencora an outperform vote.
Cencora has a net margin of 0.69% compared to Cardinal Health's net margin of 0.30%. Cencora's return on equity of 323.23% beat Cardinal Health's return on equity.
In the previous week, Cardinal Health had 40 more articles in the media than Cencora. MarketBeat recorded 45 mentions for Cardinal Health and 5 mentions for Cencora. Cencora's average media sentiment score of 0.43 beat Cardinal Health's score of 0.07 indicating that Cencora is being referred to more favorably in the news media.
Summary
Cencora beats Cardinal Health on 12 of the 20 factors compared between the two stocks.
Get Cardinal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardinal Health Competitors List
Related Companies and Tools
